Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04666428 · ClinicalTrials.gov registry record
Effects of Human Papillomavirus Diagnosis on Relationships of Patients With Head and Neck Cancer
A clinical trial, sponsored by Thomas Jefferson University.
- Completed
- Registry status
- 30
- Enrollment target
NCT04666428: Completed study, sponsored by Thomas Jefferson University.
NCT04666428 is a clinical trial that has completed, run by Thomas Jefferson University. The registered enrollment target is 30 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04666428 has completed, sponsored by Thomas Jefferson University.
- COMPLETED
- Registry status
- 30 participants
- Enrollment target
Study Summary
This trial studies the effects of human papillomavirus diagnosis on the relationships of patients with head and neck cancer. Determining the effects of human papillomavirus diagnosis on relationships may determine whether human papillomavirus-positive patients and their partners are more likely to experience decline in relationship intimacy after diagnosis than human papillomavirus-negative patients and their partners. This may help researchers provide valuable insight into the degree to which a diagnosis of human papillomavirus affects patient relationships over and above the effects of a cancer diagnosis and address the need for additional patient counseling or education following diagnosis.
Primary Outcome
Defined as total scores of the primary questions in patient survey and partner survey
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2020-01-24 |
| Est. Completion | 2023-01-03 |
What the finished NCT04666428 record still lists
NCT04666428 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 30 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT04666428 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04666428 about?
NCT04666428 is a clinical study titled "Effects of Human Papillomavirus Diagnosis on Relationships of Patients With Head and Neck Cancer". This trial studies the effects of human papillomavirus diagnosis on the relationships of patients with head and neck cancer. Determining the effects of human papillomavirus diagnosis on relationships may determine whether human papillomavirus-positive patients and their partners are more likely to e...
What is the current status of trial NCT04666428?
This trial is currently completed. The enrollment target is 30 participants. The study started on 2020-01-24. Estimated completion is 2023-01-03.
Who is sponsoring clinical trial NCT04666428?
This trial is sponsored by Thomas Jefferson University, which has 292 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00977977 · 30 participants · Phase 2
Rituximab Plus Cyclosporine in Idiopathic Membranous Nephropathy
- NCT01459107 · 30 participants · Phase 2
Human Upper Extremity Allotransplantation
- NCT01666080 · 30 participants · NA
Second or Greater Allogeneic Hematopoietic Stem Cell Transplant Using Reduced Intensity Conditioning (RIC)
- NCT01720836 · 30 participants · Phase 1
Study of the Immune Response of MUC1 (Mucin1) Peptide Vaccine for Non-small Cell Lung Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI